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Abstract
Objectives—Unhealthy lifestyle factors may contribute to apparent treatment resistant
hypertension (aTRH). We examined associations of unhealthy lifestyle factors with aTRH in
individuals taking antihypertensive medications from three or more classes.
Methods—Participants (n=2,602) taking three or more antihypertensive medication classes were
identified from the population-based REasons for Geographic And Racial Differences in Stroke
(REGARDS) study. aTRH was defined as having systolic/diastolic blood pressure ≥140/90 mmHg
despite the use of three or more antihypertensive medication classes or the use of four or more
classes to achieve blood pressure control. Lifestyle factors included obesity, physical inactivity,
current smoking, heavy alcohol consumption, a low DASH diet score and high sodium-to-
potassium (Na/K) intake.
Results—Among participants taking three or more antihypertensive medication classes, 1,293
(49.7%) participants had aTRH. The prevalence of unhealthy lifestyle factors in participants with
and without aTRH was 55.2% and 51.7% respectively for obesity, 42.2% and 40.5% for physical
inactivity, 11.3% and 11.5% for current smoking, 3.1% and 4.0% for heavy alcohol consumption,
23.1% and 21.5% for low DASH diet score, and 25.4% and 24.4% for high Na/K intake. After
adjustment for age, sex, race, and geographic region of residence, none of the unhealthy lifestyle
factors was associated with aTRH. The associations between each unhealthy lifestyle factor and
aTRH remained non-significant after additional adjustment for education, income, depressive
symptoms, total calorie intake, and co-morbidities.
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Conclusions—Unhealthy lifestyle factors did not have independent associations with aTRH
among individuals taking three or more antihypertensive medication classes.
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Introduction
A large proportion of hypertensive patients require antihypertensive medications from three
or more classes to control their blood pressure [1–3]. Cushman et al. [1] reported that
approximately one third of hypertensive participants enrolled in the Antihypertensive and
Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) were taking three or
more antihypertensive medications after 5 years of follow-up. Using data from the National
Health and Nutrition Examination Surveys (NHANES), Egan et al. [2] demonstrated that the
percentage of US adults taking multiple antihypertensive medications has steadily increased
from 1988–1994 through 2005–2008. In 2005–2008, 20% of US adults with hypertension
were taking antihypertensive medications from three or more classes [2]. Recently, using
data from the Kaiser Permanente Colorado and Northern California healthcare systems,
Daugherty et al. [3] reported that approximately 21% of patients who were newly diagnosed
with and treated for hypertension were taking antihypertensive medications from three or
more classes within three years.
Apparent treatment resistant hypertension (aTRH) is defined as blood pressure that remains
above goal despite the use of antihypertensive medications from three or more classes, or the
use of four or more antihypertensive medication classes to achieve blood pressure control
[4–7]. It has been suggested that unhealthy lifestyle factors such as obesity, physical
inactivity, smoking, heavy alcohol use, and a high salt diet contribute to aTRH [7, 8].
However, this hypothesis has not been tested in population-based studies and the prevalence
and contributions of these factors in aTRH remain uncertain, particularly among those
taking antihypertensive medications from three or more classes [8]. If unhealthy lifestyle
factors are common and independently associated with aTRH, it will highlight the need to
invest more resources in testing behavioral interventions to improve blood pressure control
in these individuals. This is particularly relevant, as the prevalence of aTRH is high and the
efficacy of lifestyle modification has not been specifically evaluated in this population [7,
8]. We, therefore, sought to evaluate the association between unhealthy lifestyle factors and
aTRH among individuals taking antihypertensive medications from three or more classes, in
the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
Methods
Study Population
The REGARDS study has been described in detail previously [9]. In brief, REGARDS is a
population-based cohort study of 30,239 adults ≥ 45 years of age from across the continental
United States. To examine the association between unhealthy lifestyle factors and aTRH, the
study population was limited to individuals who reported taking medications to lower their
blood pressure, and were on three or more classes of antihypertensive medications
(n=4,128). Participants missing blood pressure data (n=17) or information on lifestyle
behaviors (n=1,509) were excluded. Missing data on dietary intake accounted for most of
the missing information on lifestyle behaviors (n=1,385). After these exclusions, 2,602
participants were included in these analyses. The REGARDS study protocol was approved
by the Institutional Review Boards governing research in human subjects at the participating
centers and all participants provided informed consent.
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REGARDS study data were collected via a telephone interview, a self-administered
questionnaire, and in-home examination. Trained interviewers collected information on
participants’ age, education, smoking status, physical activity, alcohol consumption,
symptoms of depression and self-reports of prior physician diagnosed co-morbid conditions
(e.g., diabetes, hypertension, myocardial infarction and coronary revascularization
procedures). Elevated symptoms of depression were defined as being present for participants
with scores ≥ 4 on the 4-item Centers for Epidemiologic Studies of Depression scale [10].
Trained health professionals conducted in-home examinations which included weight,
height and blood pressure measurements, an electrocardiogram (ECG), collection of blood
and spot urine samples, and a review of medication pill bottles. Coronary heart disease
(CHD) was defined by a self-reported history or ECG evidence of myocardial infarction or a
self-reported history of a revascularization procedure. Diabetes was defined as a serum
glucose ≥ 126 mg/dL for participants who had fasted ≥ 8 hours prior to their blood draw, a
serum glucose ≥ 200 mg/dL for those who had not fasted, or a self-report of a prior
diagnosis of diabetes (excluding pregnancy induced) with the current use of insulin or oral
hypoglycemic medications. Dyslipidemia was defined as an LDL-cholesterol ≥ 160 mg/dL,
total cholesterol ≥ 240 mg/dL, HDL-cholesterol < 40 mg/dL or the self-reported use of lipid-
lowering medication. Using isotope-dilution mass spectrometry (IDMS)–traceable serum
creatinine, estimated glomerular filtration rate (eGFR) was calculated using the Chronic
Kidney Disease Epidemiology Collaboration (CKD-EPI) equation [11]. Reduced eGFR was
defined as levels < 60 ml/min/1.73 m2. Albuminuria was defined as a urinary albumin to
urinary creatinine ratio ≥ 30 mg/g. Chronic kidney disease was defined by the presence of
reduced eGFR and/or albuminuria [12]. Medication adherence was assessed using the 4-item
Morisky Medication Adherence Scale (MMAS) [13]. Each item has a yes/no response
option. One point is assigned to each “yes” response, and points are summed (totaling 0–4)
with a higher score indicating worse adherence [14].
Blood Pressure Measurement, Medication Use and aTRH
During the in-home examination, blood pressure was measured two times by trained
examiners using aneroid sphygmomanometers following a standardized protocol.
Participants were asked to sit for three minutes with both feet on the floor prior to having
their blood pressure measured; the two blood pressure measurements were averaged.
Hypertension was defined as systolic blood pressure ≥ 140 mmHg, diastolic blood pressure
≥ 90 mmHg, and/or the self-reported use of antihypertensive medications. Also, during the
in-home visit, participants were asked to provide all medications they had taken in the past
two weeks, and medication names were recorded and subsequently coded into drug classes.
Antihypertensive medication classes were defined using categories described in the Seventh
Report of the Joint National Committee on Prevention, Detection, Evaluation, and
Treatment of High Blood Pressure (JNC 7) [15]. Single-pill combinations were classified as
individual components. Information on medication dose was not recorded. Uncontrolled
hypertension was defined as a systolic blood pressure ≥ 140 mmHg or diastolic blood
pressure ≥ 90 mmHg. aTRH was defined as having uncontrolled hypertension despite the
use of antihypertensive medications from three or more classes or the use of four or more
antihypertensive medication classes to achieve blood pressure control [4–7].
Unhealthy Lifestyle Factors
Six lifestyle factors were evaluated in the current analysis: obesity, physical inactivity,
cigarette smoking, heavy alcohol consumption, a low Dietary Approaches to Stop
Hypertension (DASH) diet score and a high sodium-to-potassium (Na/K) intake. Height and
weight were measured during the in-home study visit using calibrated equipment. Body
mass index (BMI) was defined as weight in kilograms (kg) divided by height in meters (m)
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squared and obesity was defined as levels ≥ 30 kg/m2. Current smoking was determined by
affirmative responses to the following two questions “Have you smoked at least 100
cigarettes in your lifetime?” and “Do you smoke cigarettes now, even occasionally?”
Physical activity was assessed through a single question “How many times per week do you
engage in intense physical activity, enough to work up a sweat?” with response options of
“none”, “1 to 3 times per week” and “four or more times per week”. Participants who
answered “none” were considered to be physically inactive. Men and women who reported
consuming > 14 and > 7 alcoholic beverages per week, respectively, were considered to
have heavy alcohol consumption. Participants were asked to complete a self-administered
Block 98 Food Frequency Questionnaire (FFQ) following the in-home study visit [16–18].
The FFQ was used to estimate average dietary intake for one year prior to their in-home
visit. Nutrient analysis was conducted by NutritionQuest. A DASH dietary score was
created using methods similar to those described by Fung et al. [19] Using the distribution of
DASH dietary scores from participants included in the current study, a low DASH diet score
was defined by being in the lowest quartile (DASH scores <20). High Na/K intake was
defined by being in the upper quartile (Na/K ≥ 1.08). The cut-points for the lowest quartile
of the DASH diet score and highest quartile of Na/K intake were similar for men and
women and, therefore, gender specific cut-points were not used. Finally, total caloric intake
was derived by using algorithms based on the FFQ [20].
Statistical Analysis
The prevalence of aTRH was calculated for all REGARDS participants with hypertension
and for those with hypertension taking three or more antihypertensive medication classes.
The characteristics of REGARDS study participants taking three or more antihypertensive
medication classes were calculated by aTRH status with the statistical significance of
differences determined using chi square and t-tests, as appropriate. The prevalence of each
unhealthy lifestyle factor was calculated by aTRH status with the statistical significance of
differences calculated using chi-square tests. Next, using Poisson regression, we calculated
the prevalence ratio for aTRH associated with each unhealthy lifestyle behavior [21, 22].
Robust standard errors were calculated using sandwich estimators. Prevalence ratios are
recommended instead of odds ratios for cross sectional studies with common outcomes [21,
22]. Initial models included adjustment for age, sex, race, and geographic region of
residence. Subsequent models included additional adjustment for education level (less than
high school education), annual household income (<$20,000), elevated depressive
symptoms, reduced eGFR, albuminuria, diabetes, dyslipidemia, history of CHD, and total
caloric intake. Next, we calculated the distribution of the number of unhealthy lifestyle
behaviors for participants with and without aTRH. Additionally, we calculated the
prevalence ratio for aTRH associated with 1, 2, 3, and ≥4 versus no unhealthy lifestyle
behaviors. Prevalence ratios were calculated with the two levels of adjustment described
above. Three sensitivity analyses were conducted. First, as some investigators [7] have
suggested that a diuretic be one of the antihypertensive classes to meet the definition for
aTRH, we repeated the analyses excluding individuals not on a diuretic (n=385). Second, we
conducted analyses defining uncontrolled hypertension as a systolic blood pressure ≥ 140
mmHg or diastolic blood pressure ≥ 90 mmHg except for individuals with diabetes or
chronic kidney disease in whom uncontrolled hypertension was defined as systolic blood
pressure ≥ 130 mmHg or diastolic blood pressure ≥ 80 mmHg. Third, as aTRH may be
partially explained by reduced medication adherence [8], we restricted the study population
to participants who reported a high level of medication adherence, defined as a MMAS score
of 0 (n=1,771). Data analysis was conducted using SAS version 9.3 (SAS Institute, Cary,
NC).
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Of REGARDS participants with complete data for lifestyle behaviors and systolic and
diastolic blood pressure, 11,742 had hypertension. Of this group, 2,602 (22.2%) were taking
three or more antihypertensive medication classes, and 1,293 had aTRH (11.0% of all
participants with hypertension and 49.7% of those taking 3 or more antihypertensive
medication classes). Of participants with aTRH, 589 (45.6%) had uncontrolled blood
pressure despite the use of antihypertensive medications from three classes, and 704 (54.4%)
were taking antihypertensive medications from four or more classes.
Participant Characteristics
Table 1 shows the characteristics of the 2,602 participants who were taking three or more
antihypertensive medication classes. Those with aTRH were more likely to be black, male,
have less than a high school education, reduced eGFR, albuminuria, diabetes, and a history
of CHD. Those with aTRH also had a higher mean BMI (mean ± standard deviation, 31.9 ±
6.8 kg/m2 for participants with aTRH vs. 31.4 ± 6.6 kg/m2 for participants with controlled
blood pressure on three medication classes). There were no significant differences in other
participant characteristics.
Relation Between Unhealthy Lifestyle Factors and aTRH
Table 2 shows the prevalence of each unhealthy lifestyle factor (obesity, physical inactivity,
current smoking, heavy alcohol consumption, low DASH diet score, and high Na/K intake)
in participants with aTRH and participants whose blood pressure was controlled on three
antihypertensive medication classes. Participants with aTRH were more likely to be obese,
compared to participants whose blood pressure was controlled on three medication classes,
however, this difference was not statistically significant (P=0.07). There was also no
significant difference in the prevalence of physical inactivity (P=0.37), current smoking
(P=0.89), heavy alcohol use (P=0.22), low DASH diet score (P=0.33), and high Na/K intake
(P=0.56) between participants with and without aTRH. After adjustment for age, sex, race,
and geographic region of residence (Table 2, Model 1), none of the unhealthy lifestyle
factors was significantly associated with aTRH. The association between each unhealthy
lifestyle factor and aTRH remained non-significant after further multivariable adjustment
(Table 2, Model 2).
Clustering of Unhealthy Lifestyle Factors and aTRH
As shown in Figure 1, participants whose blood pressure was controlled on three medication
classes did not differ in the number of unhealthy lifestyle factors, compared with
participants with aTRH (P=0.50). After adjustment for age, sex, race, and geographic region
of residence, the association between the number of lifestyle factors and aTRH was not
statistically significant (Table 3, Model 1). The association between the number of lifestyle
factors and aTRH did not change in a fully adjusted model (Table 3, Model 2).
Sensitivity Analyses
The results were similar when we repeated the analyses restricting the sample to participants
taking three or more antihypertensive medication classes with one class being a diuretic
(Supplementary Table 1, Supplemental Digital Content 1). When defining uncontrolled
blood pressure as systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 80
mmHg for people with diabetes or chronic kidney disease, the prevalence of unhealthy
lifestyle factors with aTRH was similar to those in the primary analyses (Supplementary
Table 2, Supplemental Digital Content 1). In this analysis, there was a modest association
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between obesity and aTRH in a fully adjusted model (prevalence ratio 1.09, 95% CI 1.02 –
1.16, P=0.009). Finally, after restricting the population to participants with high medication
adherence, the results were also similar to the primary analyses (Supplementary Table 3,
Supplemental Digital Content 1).
Discussion
This study adds important information to the existing literature on aTRH. First, among
participants taking antihypertensive medications from three or more classes, the prevalence
of unhealthy lifestyle factors, particularly obesity, physical inactivity, low DASH diet score
and high Na/K intake was high regardless of whether or not participants had aTRH. Second,
none of the lifestyle factors was significantly associated with aTRH. There was a significant
association between obesity and aTRH in an analysis that defined uncontrolled hypertension
using lower cutpoints for participants with diabetes or chronic kidney disease. However, the
magnitude of this association was small. Third, the clustering of unhealthy lifestyle factors
was common in both aTRH and in those whose blood pressure was controlled on three
antihypertensive medications; and the clustering of unhealthy lifestyle factors was not
associated with aTRH.
Unhealthy lifestyle factors such as obesity, physical inactivity, smoking, heavy alcohol use,
and a high salt diet have been identified as factors underlying difficult-to-control blood
pressure [6, 8]. Obesity is associated with hypertension, higher blood pressure levels and a
greater use of multiple antihypertensive medications [1, 23–27]. Similar associations have
been reported for physical inactivity, smoking, heavy alcohol use, and a high salt diet.[28]
Thus, our finding that unhealthy lifestyle factors are common among participants taking
antihypertensive medications from three or more classes is consistent with this prior
literature.
It is unknown why unhealthy lifestyle factors was not associated with aTRH in our study.
One explanation is that the prevalence of unhealthy lifestyle factors was also relatively high
in participants whose blood pressure was controlled with antihypertensive medications from
three classes, making it difficult to ascertain differences in unhealthy lifestyle factors
between these participants and those with aTRH. For example, in our study, the prevalence
of obesity was high not only in participants with aTRH but also in participants whose blood
pressure was controlled on three antihypertensive medication classes. Similarly, in
NHANES [2], among participants on 3 or more antihypertensive medication classes, BMI
was only modestly higher in participants with uncontrolled hypertension compared to
participants with controlled hypertension in 2005–2008 (mean BMI was 32.3 kg/m2 and
31.8 kg/m2 respectively). Although obesity was higher among patients with aTRH compared
to patients who had controlled hypertension while taking antihypertensive medications from
3 classes or less in a recent analysis of the Spanish Ambulatory Blood Pressure Monitoring
Registry which included hypertensive clinic patients [29], the difference in BMI between the
two groups was modest (mean BMI was 30.8 kg/m2 and 29.3 kg/m2 respectively).
Another explanation why unhealthy lifestyle factors did not have strong associations with
aTRH is the relative contributions of other determinants of aTRH. We observed substantial
differences in race, sex, and prevalence of comorbidities, particularly measures of chronic
kidney disease and diabetes, between participants with aTRH and those with controlled
hypertension. These factors may have played an important role in the development of aTRH,
thereby diminishing the association between unhealthy lifestyle factors and aTRH.
Unhealthy lifestyle factors could also have contributed indirectly to aTRH through the
development of these comorbidities.
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JNC 7 [15] recommends that hypertensive patients undertake lifestyle modifications such as
weight reduction, increasing physical activity, moderation of alcohol consumption, adoption
of the DASH diet, dietary salt reduction, and the cessation of smoking. Most of these
interventions have been demonstrated to lower blood pressure in unselected patients with
hypertension or in those with mild to moderate hypertension [7, 8]. In contrast, the efficacy
of lifestyle modification interventions for the treatment of aTRH has been largely untested
[7, 8]. Pimenta et al. [30] showed in a small crossover study of 12 participants with aTRH
that a low salt diet reduced systolic and diastolic blood pressure by 22.7 and 9.1 mm Hg,
respectively. Therefore, salt restriction may improve blood pressure control for aTRH
participants. Future randomized controlled trials should examine whether individual or
multi-faceted lifestyle interventions can facilitate blood pressure control for patients with
aTRH, particularly those with comorbidities such as chronic kidney disease and diabetes.
This study has a number of important strengths. The REGARDS study is one of the largest
population-based cohort studies conducted in the United States. Black and white study
participants were recruited from across the continental United States, and therefore, the
findings are likely highly generalizable. Blood pressure was measured by trained technicians
following a standardized protocol and medications being taken were recorded through direct
inspection. Finally, since available data on the contribution of unhealthy lifestyle factors to
aTRH are very limited, the current study provides new data on the etiology and pathogenesis
of difficult-to-control blood pressure.
The current study also has several limitations. Many participants with aTRH may have been
on suboptimal medication doses [8]. However, medication dosing is not available in the
REGARDS study database. In addition, blood pressure levels and control were defined by
readings on a single visit. Ambulatory blood pressure monitoring was also not performed.
Therefore, it is unknown how many participants had white coat and masked resistant
hypertension. Finally, dietary measures (DASH diet and Na/K ratio) were obtained by the
FFQ, and a limitation of dietary assessment instruments is measurement error.
In conclusion, in a bi-racial, population-based sample, unhealthy lifestyle factors did not
demonstrate a strong association with aTRH among participants taking antihypertensive
medications from three or more classes. The prevalence of unhealthy lifestyle factors,
particularly obesity, physical inactivity, low DASH diet score and high Na/K intake were
high regardless of whether participants had aTRH or not. Given the increasing prevalence of
aTRH among US adults, studies are needed to assess whether lifestyle modification
interventions are effective in facilitating blood pressure control in patients with aTRH.
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Figure 1. Number of unhealthy lifestyle factors by aTRH status
Lifestyle factors include obesity, physical inactivity, current smoking, heavy alcohol
consumption, a low DASH diet score, and a high Na/K intake. Controlled hypertension was
defined as blood pressure < 140/90 mmHg. aTRH was defined as having uncontrolled
hypertension despite the use of antihypertensive medications from three or more classes or
the use of four or more antihypertensive medication classes to achieve blood pressure
control. P=0.50 comparing the distribution of the number of unhealthy lifestyle factors for
participants with and without aTRH. See Table 2 for abbreviations.
Shimbo et al. Page 10

























Shimbo et al. Page 11
Table 1






Age, years 67.3 (8.6) 67.8 (8.5) 0.182
Male, % 548 (41.9) 625 (48.3) <0.001
Black, % 546 (41.7) 669 (51.7) <0.001
Residence in stroke belt, % 458 (35.0) 460 (35.6) 0.754
Residence in stroke buckle, % 283 (21.6) 289 (22.4) 0.652
Less than high school education, % 161 (12.3) 195 (15.1) 0.039
Annual household income <$20,000, % 253 (21.9) 276 (24.3) 0.171
Elevated depressive symptoms, % 153 (11.7) 156 (12.1) 0.767
eGFR <60 ml/min/1.73 m2, % 337 (25.7) 401 (31.0) 0.003
Albuminuria, % 239 (18.3) 383 (29.6) <0.001
Diabetes, % 447 (35.2) 529 (42.2) <0.001
Dyslipidemia, % 911 (72.1) 937 (74.8) 0.124
History of CHD, % 370 (28.7) 458 (36.0) <0.001
BMI, kg/m2 31.4 (6.6) 31.9 (6.8) 0.026
Total caloric intake, g/day 1541 (1506, 1576) 1495 (1461, 1530) 0.057
*
Data are expressed as number (percentage) or mean value (SD) except total caloric intake which is expressed as geometric mean (95% confidence
interval).
†Controlled hypertension is defined as blood pressure < 140/90 mmHg.
‡
aTRH was defined as having uncontrolled hypertension despite the use of antihypertensive medications from three or more classes or the use of
four or more antihypertensive medication classes to achieve blood pressure control.
aTRH = apparent treatment resistant hypertension, BMI = body mass index, CHD = coronary heart disease, eGFR = estimated glomerular filtration
rate.
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Table 2
Prevalence ratios for aTRH* associated with individual unhealthy lifestyle factors





(n=1,293) Model 1† Model 2‡
Obesity 677 (51.7) 714 (55.2) 1.08 (1.00 – 1.17) 1.05 (0.97 – 1.15)
Physical inactivity 530 (40.5) 546 (42.2) 1.05 (0.97 – 1.13) 1.03 (0.95 – 1.12)
Current smoking 150 (11.5) 146 (11.3) 0.99 (0.88 – 1.12) 0.97 (0.86 – 1.10)
Heavy alcohol consumption 52 (4.0) 40 (3.1) 0.89 (0.70 – 1.12) 0.93 (0.73 – 1.18)
Low DASH diet score 281 (21.5) 298 (23.1) 1.03 (0.94 – 1.13) 1.03 (0.94 – 1.13)
High Na/K intake 319 (24.4) 328 (25.4) 1.00 (0.91 – 1.09) 1.01 (0.92 – 1.11)
*
aTRH was defined as having uncontrolled hypertension despite the use of antihypertensive medications from three or more classes or the use of
four or more antihypertensive medication classes to achieve blood pressure control.
†
Model 1 adjusted for age, sex, race, and geographic region of residence.
‡
Model 2 adjusted for covariables in Model 1 + education level (less than high school education), annual household income (<$20,000), elevated
depressive symptoms, reduced estimated glomerular filtration rate (<60 ml/min/1.73 m2), albuminuria (≥ 30 mg/g), diabetes, dyslipidemia, history
of coronary heart disease, and total caloric intake.
aTRH = apparent treatment resistant hypertension, CI = confidence interval, DASH = Dietary Approaches to Stop Hypertension, Na/K = sodium-
to-potassium.
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Table 3
Prevalence ratios for aTRH* associated with number of unhealthy lifestyle risk factors †
Prevalence ratio (95% CI)
Number of unhealthy lifestyle factors Model 1‡ Model 2§
0 1.00 (ref) 1.00 (ref)
1 0.97 (0.86 – 1.09) 0.96 (0.85 – 1.08)
2 1.03 (0.92 – 1.16) 1.02 (0.90 – 1.15)
3 1.02 (0.89 – 1.18) 1.01 (0.88 – 1.17)
≥ 4 1.11 (0.93 – 1.32) 1.07 (0.89 – 1.28)
*
aTRH was defined as having uncontrolled hypertension despite the use of antihypertensive medications from three or more classes or the use of
four or more antihypertensive medication classes to achieve blood pressure control.
†
Lifestyle factors include obesity, physical inactivity, current smoking, heavy alcohol consumption, a low DASH diet score, and a high Na/K
intake.
‡
Model 1 adjusted for age, sex, race, and geographic region of residence.
§
Model 2 adjusted for covariables in Model 1 + education level (less than high school education), annual household income (<$20,000), elevated
depressive symptoms, reduced estimated glomerular filtration rate (<60 ml/min/1.73 m2), albuminuria (≥ 30 mg/g), diabetes, dyslipidemia, history
of coronary heart disease, and total caloric intake.
See Table 2 for abbreviations.
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